Published January 2004 | Version v1
Miscellaneous

Well differentiated thyroid carcinoma treatment with 131i and its follow up in Paraguay

  • 1. Department of Nuclear Medicine at the Health Sciences Research Institute, National University of Asuncion (Paraguay)
  • 2. Department of Surgery, Nazarene Hospital (Paraguay)

Description

Paraguay is a South American country with the highest prevalence in goiter (48.6%). During a 15-year period, from 1987 to 2002, 200 patients with well differentiated thyroid carcinoma were treated with 131I, post-surgery at ages between 18 and 60 years old

Availability note (English)

Available from Centro de Informacion Nuclear, Comision Nacional de Energia Atomica, Universidad Nacional de Asuncion, San Lorenzo CP 2169, PO Box 3029 Asuncion (PY)

Additional details

Identifiers

Publishing Information

Imprint Pagination
7 p.

INIS

Country of Publication
Paraguay
Country of Input or Organization
Paraguay
INIS RN
35105805
Subject category
S61: RADIATION PROTECTION AND DOSIMETRY;
Resource subtype / Literary indicator
Non-conventional Literature
Descriptors DEI
CARCINOMAS; IODINE 131; NUCLEAR MEDICINE; RADIOTHERAPY; THYROID
Descriptors DEC
BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BODY; DAYS LIVING RADIOISOTOPES; DISEASES; ENDOCRINE GLANDS; GLANDS; INTERMEDIATE MASS NUCLEI; IODINE ISOTOPES; ISOTOPES; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; NUCLEI; ODD-EVEN NUCLEI; ORGANS; RADIOISOTOPES; RADIOLOGY; THERAPY